跳转到主要内容
搜索

发现、学习、应用

欢迎访问 Certara 资源中心 - 科学好奇心和胆识的宝库。无论您是要解决复杂的药代动力学问题，还是要制定提交监管申请的策略，我们精心策划的资源都能帮助您通过模型引导的药物开发、严格的监管和数据协调，更快地找到新的发展方向。

注册

最新资源

即将举行的网络研讨会

典型案例研究

查看全部
优化 Charles River 实验室的药代动力学工作流程
Charles River
优化 Charles River 实验室的药代动力学工作流程

优化 Charles River 实验室的药代动力学工作流程

重塑医药未来：Biohaven 公司 Nurtec™ 药物的研发之旅
Biohaven
重塑医药未来：Biohaven 公司 Nurtec™ 药物的研发之旅

重塑医药未来：Biohaven 公司 Nurtec™ 药物的研发之旅

肿瘤学剂量选择中模型引导的决策信心
Sutro Biopharma
肿瘤学剂量选择中模型引导的决策信心

肿瘤学剂量选择中模型引导的决策信心

在以下活动中与我们的专家会面

药物开发方面的培训和支持

培训

通过深入的实践培训模块提高团队技能。

了解更多信息

支持

获取专家建议，优化您的 Certara 解决方案。

访问支持中心

浏览全部资料库

释放寡核苷酸疗法的力量：与 Certara 和 Ionis 合作，采用基于模型的方法

临床药理学，网络研讨会

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pediatrics, Video

战略与执行衔接：Sophia Fong 的药物开发之道

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pediatrics, Video

科学背后的故事：Meet Sr. Director Craig Comisar

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Video

Meet Floris Fauchet: From Model-Based Drug Development to Martial Arts

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pediatrics, Video

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

ADC, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, PopPK Modeling and Simulation, Regulatory, Therapeutic Specialties, Publication

科学背后的故事：与 Katrina Hui 的对话

Certara 服务、临床药理学、临床试验 、药物开发、模型引导的药物开发、视频

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

Biologics, Certara Products, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Publication

利用模拟结果为探索全人源抗 IL-6 抗体 TOUR006 治疗甲状腺眼病的 IIb 期试验确定剂量

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Formulation, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, PopPK Modeling and Simulation, Poster

为何 FDA 批准 omaveloxolone 用于治疗弗里德赖希共济失调症意义重大

Clinical Pharmacology, Early clinical - Blog, Late clinical - blog, Rare and Neglected Diseases, Therapeutic Specialties, Blog

利用基于模型的荟萃分析 (MBMA) 解决药物开发难题

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, On-Demand Webinar

INTERCEPT-AD：一项针对阿尔茨海默病所致轻度认知障碍或轻度痴呆患者的静脉注射 Sabirnetug 的 I 期研究

Certara Products, Certara Services, Clinical Pharmacology, Clinical Trials, CODEX, Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation - PK/PD, Pharmacometrics, PK/PD, Real World Data, Publication
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，也是我们的执着追求。如果这也是您的目标，那么请第一时间了解我们的新见解，与我们一起推动科学进步。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software